Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through Medicaid or state employee insurance programs are scrambling to lessen the budget ...
Explícame on MSN15h
There will be no weight-loss drugs for these Social Security retireesIn a recent decision, the Centers for Medicare and Medicaid Services have declined a proposal to expand Medicare coverage for ...
The Centers for Medicare and Medicaid Services said late Friday that it would not cover medications such as Wegovy that are ...
President Donald Trump’s team is rejecting former President Biden's plan to cover weight loss drugs like Wegovy and Zepbound for older Americans through Medicare. The Centers for Medicare and Medicaid ...
President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the ...
The Trump administration has chosen not to finalize a rule proposed by the Biden administration that would have allowed ...
The Centers for Medicare and Medicaid Services (CMS) announced Friday it will not be finalizing a rule proposed by the Biden ...
Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.
The Biden administration proposal would have significantly expanded access to obesity to millions of Americans but would have cost the government billions.
It seems like everyone and their sister is taking a GLP-1 (“glucagon-like peptide-1 receptor agonists,” if you’re feeling nasty), or is at least thinking about it. These meds—which include Ozempic, ...
The telehealth company Hims & Hers is adding Zepbound and generic liraglutide to its offering of weight-loss drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback